Brief: Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea

Fortress Biotech

06/12/2023 13:14

Dec 6 (Reuters) - Journey Medical Corp  DERM.O :
    * JOURNEY MEDICAL CORPORATION ANNOUNCES SUCCESSFUL
COMPLETION OF
PRE-NDA MEETING WITH THE FDA FOR DFD-29 TO TREAT ROSACEA
    * JOURNEY MEDICAL - FDA AGREED THAT PROPOSED DATA PACKAGE
SUFFICIENT TO SUPPORT NDA SUBMISSION, CONTINUES TO ANTICIPATE
WILL OCCUR AROUND 2023 YEAR-END

Source text for Eikon:  ID:nGNX1lk4hM 
Further company coverage:  DERM.O 

 ((Reuters.Briefs@thomsonreuters.com;))